PRDX2 and Parkinson disease: Furthermore, the pharmacological inhibition of histone deacetylase 6 (HDAC6) by tubastatin A (TBA) could reduce NLRP3 inflammasome activation and protect DA neurons by peroxiredoxin 2 (Prx2) acetylation [41], thereby improving the PD process.